(Q42212281)
Statements
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors (English)
A Forcina
D Clerici
R Crocchiolo
M T L Stanghellini
M Noviello
C Messina
A Crotta
A Assanelli
S Marktel
S Olek
S Mastaglio
F Giglio
L Crucitti
A Lorusso
E Guggiari
F Lunghi
M Carrabba
M Tassara
A Ferraro
M R Carbone
G Oliveira
S Rossini
M Bernardi
C Corti
M Marcatti
F Patriarca
F Locatelli
K Fleischhauer
A Bondanza
F Ciceri
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference